Discovery of steroid sulphatase inhibitors recognised with GSK award
The achievements of two researchers who contributed to the discovery of steroid sulphatase inhibitors were recognised earlier this week at the British Pharmaceutical Conference held in Manchester from 6 to 9 September 2009.
Barry Potter, professor of medicinal and biological chemistry at the University of Bath, and the late Michael Reed, professor of steroid biochemistry at Imperial College, London, won the 2009 GlaxoSmithKline International Achievement Award.
The award was presented in recognition of their contribution to the discovery of steroid sulphatase inhibitors, being investigated in clinical trials as anticancer agents by Ipsen.
Professor Potter said: “Winning the GSK International Achievement Award is a great honour and a most welcome recognition of the interdisciplinary work that Professor Reed and I have led for almost two decades. Modern clinical drug discovery is a team effort and rarely achieved in academia. We accept this award also on behalf of other talented scientific colleagues at both institutions whose contributions are warmly acknowledged.”
Professor Potter delivered a lecture, entitled “Steroid sulphatase inhibitors: from concept to clinic”, at the conference, a report from which will appear in the BPC supplement to be distributed with The Pharmaceutical Journal in October.
Citation: The Pharmaceutical Journal URI: 10977876
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com